Impax Laboratories Email Format
Pharmaceutical ManufacturingCalifornia, United States201-500 Employees
Amneal Pharmaceuticals, Inc., formed by the merger of Impax Laboratories and Amneal Pharmaceuticals LLC, operates in pharmaceutical manufacturing with a focus on generics and a growing branded portfolio. The company is based in Hayward, California, and trades on the New York Stock Exchange under the ticker AMRX. Its customers include healthcare providers and patients seeking affordable medicines, reflecting its position in the U.S. generics and branded pharmaceutical space. Recent news notes the U.S. FDA approval of romidepsin injection solution.